New advances in the treatment of Clostridium difficile infection (CDI)

Dennis D Hedge, Joe D Strain, Jodi R Heins, Debra K FarverSouth Dakota State University College of Pharmacy, Brookings, SD 57007, USAAbstract: Clostridium difficile infections (CDI) have increased in frequency throughout the world. In addition to an increase in frequency, recent CDI epidemics have b...

Full description

Saved in:
Bibliographic Details
Main Authors: Dennis D Hedge (Author), Joe D Strain (Author), Jodi R Heins (Author), Debra K Farver (Author)
Format: Book
Published: Dove Medical Press, 2008-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4e89e9c79b614328818305ccab07781c
042 |a dc 
100 1 0 |a Dennis D Hedge  |e author 
700 1 0 |a Joe D Strain  |e author 
700 1 0 |a Jodi R Heins  |e author 
700 1 0 |a Debra K Farver  |e author 
245 0 0 |a New advances in the treatment of Clostridium difficile infection (CDI) 
260 |b Dove Medical Press,   |c 2008-09-01T00:00:00Z. 
500 |a 1176-6336 
500 |a 1178-203X 
520 |a Dennis D Hedge, Joe D Strain, Jodi R Heins, Debra K FarverSouth Dakota State University College of Pharmacy, Brookings, SD 57007, USAAbstract: Clostridium difficile infections (CDI) have increased in frequency throughout the world. In addition to an increase in frequency, recent CDI epidemics have been linked to a hypervirulent C. difficile strain resulting in greater severity of disease. Although most mild to moderate cases of CDI continue to respond to metronidazole or vancomycin, refractory and recurrent cases of CDI may require alternative therapies. This review provides a brief overview of CDI and summarizes studies involving alternative antibiotics, toxin binders, probiotics, and immunological therapies that can be considered for treatment of acute and recurrent CDI in severe and refractory situations.Keywords: Clostridium difficile, antibiotics, probiotics, immunological therapy 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Therapeutics and Clinical Risk Management, Vol 2008, Iss Issue 5, Pp 949-964 (2008) 
787 0 |n http://www.dovepress.com/new-advances-in-the-treatment-of-emclostridium-difficileem-infection-c-a2246 
787 0 |n https://doaj.org/toc/1176-6336 
787 0 |n https://doaj.org/toc/1178-203X 
856 4 1 |u https://doaj.org/article/4e89e9c79b614328818305ccab07781c  |z Connect to this object online.